Trial Profile
Reversibilite sous Tiotropium (SPIRIVA) chez les patients BPCO : parametres EFR, dyspnee et TDM
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2011
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms REVERSPIR
- 24 Aug 2011 New trial record